跳至主要内容
临床试验/NCT00036712
NCT00036712Unknown2 期

A Multiinstitutional Trial To Evaluate The Prophylactic Use Of NASA-Developed Light Emitting Diodes For The Prevention Of Oral Mucositis In Bone Marrow Transplant Patients

Medical College of Wisconsin2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2002年1月最近更新:
适应症

试验速览

阶段
2 期
入组人数
80
试验地点
2
主要终点
Mean change in oral mucositis index (OMI) score from baseline to maximum score within 14 days posttransplant

研究概览

简要总结

RATIONALE: Light-emitting diode (LED) therapy may be able to prevent mucositis of the mouth.

PURPOSE: Randomized phase II trial to determine the effectiveness of LED therapy in preventing mucositis of the mouth in children who are receiving chemotherapy with or without radiation therapy before donor bone marrow transplantation.

详细描述

OBJECTIVES:

  • Compare the incidence and severity of oral mucositis in children undergoing NASA-developed light-emitting diode (LED) therapy during a pre-transplantation myeloablative conditioning regimen (chemotherapy with or without radiotherapy) and continuing through the post-bone marrow transplantation (BMT) phase versus LED therapy during the post-BMT phase only.

OUTLINE: This is a randomized, double-blind, multicenter study. Patients are stratified according to participating center and cheek being treated (right vs left). Patients are randomized to 1 of 2 schedules of light-emitting diode (LED) therapy.

  • Arm I: Patients undergo LED therapy for 71 seconds once daily beginning on day 1 of the myeloablative conditioning regimen comprising chemotherapy with or without radiotherapy and continuing for 14 days after bone marrow transplantation (BMT).
  • Arm II: Patients undergo LED therapy as in arm I beginning on the day of BMT (day 0) and continuing for 14 days after BMT.

Photographs are taken of the right and left buccal mucosa at baseline and then every 3 days beginning on day 1 of LED therapy.

研究设计

研究类型
Interventional
主要目的
Supportive Care

入排标准

年龄范围
2 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Mean change in oral mucositis index (OMI) score from baseline to maximum score within 14 days posttransplant

Mean change in pain score from baseline to maximum score within 14 days posttransplant

Proportion of patients not experiencing ulcerative mucositis within the first 14 days posttransplant

次要结局

  • Time to heal

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Light-Emitting Diode Therapy in Preventing Mucositis... | 临床试验